Occupational HealthLink, Inc. – Trademark Portfolio
Entity Type: 03
Occupational HealthLink, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AXION HEALTH. The owner is based in Denver, CO.
Suite 150
Denver, CO 80202
Showing of trademarks Trademarks
Trademark Classifications
Occupational HealthLink, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Occupational HealthLink, Inc. have?
Occupational HealthLink, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Occupational HealthLink, Inc. file in?
Occupational HealthLink, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Occupational HealthLink, Inc.'s most well-known trademarks?
Occupational HealthLink, Inc.'s registered trademark portfolio includes well-known marks such as AXION HEALTH. These are among 1 currently registered trademark in the portfolio.
What is Occupational HealthLink, Inc.'s trademark registration success rate?
Occupational HealthLink, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.